Targeted Medical Pharma

Targeted Medical Pharma AAQS

The The AAQS of Targeted Medical Pharma (TRGM) as of Nov 16, 2026 is 3. In the previous year, The AAQS was 3.00 — a change of 0.00% (lower).

AAQS

3

YoY

0.00%

Last updated:

Targeted Medical Pharma has a current AAQS of 3.

A high AAQS can be seen as a positive indicator that the company is developing successfully.

Investors can assume that the company is on a good path to generate profits.

On the other hand, it is important to consider the AAQS of the stock Targeted Medical Pharma in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.

In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.

The Targeted Medical Pharma AAQS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

AAQS
Date
AAQS
Jan 1, 2014
3.00 USD
Jan 1, 2015
3.00 USD
The Targeted Medical Pharma AAQS history
YEARAAQSYoY
30.00%
3—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Targeted Medical Pharma Stock analysis

What does Targeted Medical Pharma do? Targeted Medical Pharma Inc is a California-based biotechnology company that focuses on the development and marketing of patented pharmaceutical products in the field of neuroscience and pulmonology. The company was founded in 1999 and has since placed emphasis on the development of patented pharmaceutical products that can be used in various medical areas. The main business model of Targeted Medical Pharma is to bring innovative product developments to the market that can bridge the gap between conventional medicine and integrative medicine. The company aims to create therapy options that are very specific to certain diseases, which can then be patented and marketed. However, disposable drugs (medicines that need to be administered once a year and then have long-term effects), as one knows from other companies, are not used. The company offers a wide range of different divisions and products that have been developed over the years. The main divisions covered by Targeted Medical Pharma include: 1. Neurology: Here, the company develops products for the treatment of neurological disorders such as ADHD, Alzheimer's, autism, depression, stroke, and other diseases of the central nervous system. 2. Pain management: In this division, Targeted Medical Pharma focuses on the development of products against chronic pain, back pain, and migraines. 3. Sports medicine: The goal of this division is to help athletes improve their performance and recovery and to prevent injuries. 4. Pulmonology: Here, Targeted Medical Pharma offers products targeting the treatment of lung problems such as asthma and COPD. Some of the well-known products developed by Targeted Medical Pharma include: 1. Sentra AM: A dietary supplement specifically developed to support the nervous system and used for the treatment of depression, anxiety, and other neurological disorders. 2. Theramine: A patented amino acid mixture developed for chronic pain, supporting the body in pain relief and fighting inflammation. 3. Aeropur: An inhalation device specifically developed for the treatment of asthma and COPD. 4. Clearwayz: A solution that helps loosen mucus and clear airways during colds and bronchitis. 5. Trepadone: A dietary supplement developed in collaboration with the US Navy to reduce inflammation and muscle soreness after intense physical training and improve recovery. The company has earned great respect in the industry and among investors, particularly through the continuous development of new products and emphasis on scientific research and clinical evidence. A seven-figure number of patients can benefit from these innovations. Targeted Medical Pharma has worked on the development of more than 25 different patented pharmaceutical products, several of which have already been approved by the FDA (Food and Drug Administration). The company has also established numerous valuable connections with academic institutions and healthcare facilities, which is expected to benefit the development of new and innovative products. Overall, Targeted Medical Pharma is a company specializing in patented product development. In fact, it is working hard to revolutionize the complementary medicine field by creating innovative therapies and treatments to have a lasting positive impact on the health and well-being of millions of people worldwide. Targeted Medical Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Targeted Medical Pharma stock

The AAQS of Targeted Medical Pharma is 3 in 2015.

On Eulerpool you can find the complete historical development of The AAQS Targeted Medical Pharma since 2006 – with annual values, charts, and detailed analysis.

The AAQS is a key figure developed by AlleAktien.

The AAQS is a key figure developed by AlleAktien.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Targeted Medical Pharma

All Key Metrics — Targeted Medical Pharma